BridgeBio Pharma, Inc. (BBIO)

CIK 1743881 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for BridgeBio Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Nov 3, 202640001470831-26-000976
Oct 29, 202610-Q0001743881-26-000034
Oct 29, 20268-K0001743881-26-000033
Oct 27, 2026SCHEDULE 13G0002012383-26-003764
Oct 13, 20268-K0001140361-26-039334
Sep 21, 202640001470831-26-000897
Aug 31, 20268-K0001140361-26-035055
Aug 20, 202640001470831-26-000848
Aug 19, 20261440001950047-26-008424
Aug 18, 202640001470831-26-000837
Aug 18, 20261440001950047-26-008337
Aug 18, 202640001470831-26-000835
Aug 18, 202640001470831-26-000836
Aug 17, 2026SCHEDULE 13D/A0001140361-26-033404
Aug 17, 20261440001950047-26-008246
Aug 17, 20268-K0001140361-26-033282
Aug 14, 2026424B70001140361-26-032934
Aug 10, 20268-K0001743881-26-000026
Aug 10, 202610-Q0001743881-26-000027
Aug 3, 202640001470831-26-000745
Aug 3, 2026SCHEDULE 13G/A0000908834-26-000369
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002210
Jul 24, 2026S-80001140361-26-029623
Jul 24, 2026S-3ASR0001140361-26-029624
Jul 22, 20268-K0001140361-26-029291